Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | MMP8 | P22894 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL805646 | 1.00 | GAA (0.62) | GAAKDM4EL3MBTL1TDP1MMP8 | |
| SCHEMBL23027214 | 1.00 | GAA (0.62) | GAAKDM4EL3MBTL1TDP1MMP8 | |
| Hydrogen Sulfide SCHEMBL28874620 | 0.98 | GAA (0.60) | GAAKDM4EL3MBTL1TDP1MMP8 | |
| Hydrogen Sulfide SCHEMBL27877648 | 0.98 | GAA (0.60) | GAAKDM4EL3MBTL1TDP1MMP8 | |
| Hydrazine SCHEMBL27358872 | 0.96 | GAA (0.59) | GAAKDM4EL3MBTL1TDP1MMP8 | |
| SCHEMBL28434406 | 0.90 | GAA (0.52) | GAAKDM4EL3MBTL1TDP1MMP8 | |
| SCHEMBL5972492 | 0.89 | MMP8 (0.56) | GAAKDM4ETDP1MMP8MEN1 | |
| SCHEMBL5811954 | 0.87 | MMP8 (0.54) | GAAKDM4EMMP8MEN1KMT2A | |
| SCHEMBL10635430 | 0.87 | MMP8 (0.54) | GAAKDM4EMMP8MEN1KMT2A | |
| SCHEMBL2222145 | 0.86 | GAA (0.55) | GAAKDM4EL3MBTL1TDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110487924-B | Method for detecting cigarette perfuming uniformity based on additional marker | 上海烟草集团有限责任公司 | 2022-04-01 | — | — | CN | claimed |
| CN-113278604-A | Method for hydrolyzing and splitting 2-phenylbutyric acid enantiomer by using immobilized lipase as catalyst | 湖南理工学院 | 2021-08-20 | — | — | CN | claimed |
| CN-110300791-A | Quantum dot dispersion, self-luminous photosensitive resin composition, color filter, and image display device | 东友精细化工有限公司 | 2019-10-01 | — | — | CN | claimed |
| CN-109609217-A | A kind of high fuel value natural gas | 江苏信驰能源科技有限公司 | 2019-04-12 | — | — | CN | claimed |
| CN-109609218-A | A kind of combustion of natural gas synergist | 江苏信驰能源科技有限公司 | 2019-04-12 | — | — | CN | claimed |
| CN-109096424-A | A kind of catalyst and olefine polymerizing process for olefinic polymerization | 中国石油化工股份有限公司 | 2018-12-28 | — | — | CN | claimed |
| CN-109096418-A | A kind of catalyst and olefine polymerizing process for olefinic polymerization | 中国石油化工股份有限公司 | 2018-12-28 | — | — | CN | claimed |
| CN-109096419-A | A kind of catalyst and olefine polymerizing process for olefinic polymerization | 中国石油化工股份有限公司 | 2018-12-28 | — | — | CN | claimed |
| CN-109096417-A | A kind of catalyst and olefine polymerizing process for olefinic polymerization | 中国石油化工股份有限公司 | 2018-12-28 | — | — | CN | claimed |
| CN-109096421-A | A kind of catalyst and olefine polymerizing process for olefinic polymerization | 中国石油化工股份有限公司 | 2018-12-28 | — | — | CN | claimed |
| US-7253299-B2 | Process for purifying n2-(1(s)-ethoxycarbonyl-3-phenylpropyl)-n6-thifluoroacetyl-l-lysine | KANEKA CORPORATION (JP) | 2007-08-07 | — | — | US | claimed |
| US-7071349-B2 | Purification method of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine | KANAKA CORPORATION (JP) | 2006-07-04 | — | — | US | claimed |
| EP-1284957-A4 | PURIFICATION METHOD OF N-(1(S)-ETHOXYCARBONYL-3-PHENYLPROPYL)-L-ALANINE | KANEKA CORP (JP) | 2004-12-29 | — | — | EP | claimed |
| US-20040147773-A1 | Process for purifying n2-(1(s)-ethoxycarbonyl -3-phenylpropyl)-n6-thifluoroacetyl-l-lysine | KANEKA CORPORATION (JP) | 2004-07-29 | — | — | US | claimed |
| EP-1405845-A1 | METHOD FOR PURIFYING N2-(1(S)-ETHOXYCARBONYL-3-PHENYLPROPYL)-N6-TRIFLUOROACETYL-L-LYSINE | KANEKA CORPORATION (JP) | 2004-04-07 | — | — | EP | claimed |
| US-20030162991-A1 | Purification method of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine | KANEKA CORPORATION (JP) | 2003-08-28 | — | — | US | claimed |
| EP-1284957-A1 | PURIFICATION METHOD OF N-(1(S)-ETHOXYCARBONYL-3-PHENYLPROPYL)-L-ALANINE | KANEKA CORPORATION (JP) | 2003-02-26 | — | — | EP | claimed |
| WO-2002074728-A1 | PURIFICATION METHOD OF N-(1(S)-ETHOXYCARBONYL-3-PHENYLPROPYL)-L-ALANINE | KANEKA CORPORATION (JP) | 2002-09-26 | — | — | WO | claimed |
| CN-1003124-B | Method for synthesizing ben butyl propylprolic acid | 国家医药管理局上海医药工业研究院 | 1989-01-25 | — | — | CN | claimed |
| CN-85105258-A | Process for synthesising enalapril | — | 1986-12-31 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162991-A1 | Purification method of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine | ANPEP, NPEPPS, ADH1A | GAA 598/4885KDM4E 3734/4885L3MBTL1 80/4885 |
| US-20040147773-A1 | Process for purifying n2-(1(s)-ethoxycarbonyl -3-phenylpropyl)-n6-thifluoroacetyl-l-lysine | KARS1, L3MBTL1, PKN2 | GAA 1810/4885KDM4E 139/4885L3MBTL1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.